L. Nicolas Gonzalez Castro MD, PhDAssociate Neurologist, Department of Neurology, Brigham and Women's Hospital; Neuro-Oncologist, Center for Neuro-Oncology, Dana-Farber Cancer Institute; Assistant Professor of Neurology, Harvard Medical School, Boston, MA
Nicolas Gonzalez Castro, MD, PhD is a neurologist and neuro-oncologist at the Department of Neurology, Brigham and Women's Hospital, and Center for Neuro-Oncology, Dana-Farber Cancer Institute. He trained in systems neuroscience and computational biology as an MD-PhD student at the Harvard-MIT Division of Health Sciences and Technology, and completed his neurology residency at the Harvard Neurology Residency Program (Massachusetts General Hospital / Brigham and Women's Hospital). He did his neuro-oncology training at the Massachusetts General Hospital Cancer Center / Brigham and Women's Hospital - Dana Farber Cancer Center Fellowship Program. His current research focus is in understanding the cellular programs that underlie differentiation, survival and resistance to treatment in primary brain tumors.
DisclosuresDr. Gonzalez Castro reports the following disclosures:
Elsevier, Oakstone Publishing, BMJ Best Practice, Teladoc. Research funding from Merck & Co (to the Dana-Farber Cancer Institute).
His spouse receives salary and stock from Takeda Pharmaceuticals.
Recent Contributions to PracticeUpdate:
- IDH-Mutant Gliomas: A Society for Neuro-Oncology Consensus Review on Diagnosis, Management, and Future Directions
- Treatment of Leptomeningeal Metastases From Triple-Negative Breast Cancer
- Cellular Architecture of Human Brain Metastases
- Treatment of Primary CNS Lymphoma Refractory to High-Dose Methotrexate
- Managing Progressive Diffuse Midline Glioma H3 K27M-Mutant
- Fatty Acid Synthesis Is Required for Breast Cancer Brain Metastasis
- Treating a Symptomatic Glioma in a Pregnant Patient
- Treating a Brain Lesion Without a Tissue Diagnosis
- TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas